Clinical Trial Update: XIENCE Xpedition/Alpine/Sierra in Routine Clinical Practice

View source ↗

Summary

A completed clinical trial update on XIENCE Xpedition/Alpine/Sierra drug-eluting stents in routine clinical practice for coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• XIENCE Xpedition/Alpine/Sierra (everolimus)

Snippet

Sponsor: Seung-Jung Park | Conditions: Percutaneous Transluminal Coronary Angioplasty, Coronary Artery Disease | Status: COMPLETED